Public-private partnerships (PPPs) are important elements of efforts to assist a variety of partners in reducing exposure to the infiltration of criminal elements in drug production, supply chains and related commercial links, where drug trafficking capitalizes upon weak control structures. PPPs are effective if and when strong, with lessons learned, new procedures continuously embedded, and successes transferred into consecutive initiatives. It is clear that challenges remain, as not one partnership model fits all.
Recognizing this, and the aforementioned challenges, UNODC initiated a project to provide Member States and Private Sector entities with access to better information on PPPs addressing the world drug problem, and tools with which to facilitate the establishment of new PPPs. In addition to developing the Compendium of Public Private Partnerships in the Drug Control Area, UNODC convened two group meetings of experts from across the public and private sector in order to develop a roadmap to chart how to develop and sustain effective PPP partnerships moving forward. A third meeting was also held under the guidance and organization of the International Narcotics Control Board (INCB), drawing upon its experience of practical examples of cooperation among private and public sector operators in precursor control.
At these meetings, promising practices and lessons learned from selected experiences of PPPs in the drug control area were shared between Member States and private sector entities. This digital roadmap has collected these practices and tips into a document series, recommending coherent and coordinated approaches and action points on how to establish or sustain PPPs in order to strengthen multi-stakeholder responses to three specific areas of drug control. Moreover, it discusses the merits and potential challenges of PPPs in each of the respective areas.
These documents can now be viewed using the links below, each independently of the others. Readers with an interest in a particular aspect of PPPs in drug control may access that which they find relevant.